Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study.
BMJ Open Diabetes Res Care
; 11(6)2023 11.
Article
in En
| MEDLINE
| ID: mdl-37949470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
/
Melanoma
Limits:
Humans
Language:
En
Journal:
BMJ Open Diabetes Res Care
Year:
2023
Document type:
Article
Affiliation country:
Canadá